Gerald Cagle - Director, Clearside Biomedical, Inc
As of June 26, 2018
Gerald Cagle Net Worth
- Net worth is estimated to be at least $472.94K
- Owns at least 37,505 units of Clearside Biomedical, Inc stock
- Sold an estimated value of $14 in the last 2 years at Clearside Biomedical, Inc
Gerald Cagle Trading
- Largest purchase of shares was 14,064 units , worth over $99.85K on May 1, 2017
- Largest sale of shares was 2 units , worth over $14 on June 7, 2016
- In total has made about 10 transactions over 2 years
- Usually trades in June, with the busiest year in 2017
Gerald Cagle
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Gerald Cagle Mailing Address
- Mailing address is 135 U.S. Highway 206 Suite 15 Bedminster NJ 07921 NJ
Clearside Biomedical, Inc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| George Lasezkay | 2020 | $503,313 | $286,513 | $402,827 | $163,577 | $14,777 | $1,371,007 |
| George Lasezkay | 2019 | $371,235 | $181,772 | $299,915 | $159,809 | $32,461 | $1,045,192 |
| Charles A. Deignan | 2020 | $342,876 | $59,250 | $152,010 | $78,004 | $9,450 | $641,590 |
| Charles A. Deignan | 2019 | $332,890 | $105,264 | $107,753 | $106,000 | $9,300 | $661,207 |
| Thomas Ciulla | 2020 | $367,375 | $59,250 | $152,010 | $83,578 | $9,450 | $671,663 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1539029/000119312521135345/d59948ddef14a.htm
Clearside Biomedical, Inc Insider Trading
- The most recent transaction was 2,560 units sold on September 23, 2021 by Thomas Ciulla worth over $16.38K
- In the last 5 years, insiders at Clearside Biomedical, Inc sold an estimated value of $11.81M and bought an estimated value of $13.77M
- The most active traders are Clay Thorp, Director, Charles Deignan, Chief Financial Officer, and George Lasezkay, CEO
- Insider trading is most common in June, with the busiest year in 2017
Clearside Biomedical, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||